Chao Cheng

11PUBLICATIONS
65CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 14, 2026
ZDHHC17-Mediated CDK4 Palmitoylation Drives Cell Cycle Progression and Orchestrates Cancer Immune Surveillance.

|Nov 21, 2025
Induction chemotherapy plus camrelizumab followed by concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma: a single-arm phase II trial.

Fang Peng, Jialiang Wu, Huimin Lian

|Oct 15, 2025
18F-FDG PET/CT and contrast-enhanced CT evaluation of lymph node status after neoadjuvant immunochemotherapy in patients with esophageal squamous cell carcinoma.

Yuhong Wang, Xin Hu, Tianhong Yang

|Mar 27, 2025
TP53-centric ctDNA complements PET/CT for non-invasive assessment of pathological complete response and survival after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma: a prospective cohort study.

Weixiong Yang, Si-Cong Ma, Zengli Fang

|Jun 26, 2024
The N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma.

Shiyan Wang, Yong Zeng, Lin Zhu

|Apr 12, 2024
Chemotherapy versus chemotherapy plus immune checkpoint inhibitors for the first-line treatment of unresectable thymic carcinoma: A multicenter retrospective study.

Baishen Zhang, Yao Liu, Zhiting Chen

Pageof 2

Frequent Collaborators

4 joint publications

Weixiong Yang

2 joint publications

Yan Guo

2 joint publications

Yu Zeng

2 joint publications

Yiran Li